(Q38788203)

English

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

scientific article published on 21 March 2016

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

title

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

main subject

angiogenesis inhibitor

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

Roberto Ronca

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

author name string

Paola Chiodelli

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

Sara Matarazzo

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

Marco Rusnati

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

Marco Presta

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

publication date

22 March 2016

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

published in

Pharmacological Research

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

volume

107

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

page(s)

172-185

1 reference

stated in

Europe PubMed Central

PubMed ID

27013279

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27013279%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 March 2020

cites work

Philinopside A, a novel marine-derived compound possessing dual anti-angiogenic and anti-tumor effects

(Q38788203)

Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)